Items where authors include "Altmann, D.M."

Article

Abhishek, A., Peckham, N., Pade, C. et al. (65 more authors) (2024) Effect of a 2-week interruption in methotrexate treatment on COVID-19 vaccine response in people with immune-mediated inflammatory diseases (VROOM study): a randomised, open label, superiority trial. The Lancet Rheumatology, 6 (2). e92-e104. ISSN 2665-9913

Abhishek, A., Boyton, R.J., McKnight, Á. et al. (15 more authors) (2022) Effects of temporarily suspending low-dose methotrexate treatment for 2 weeks after SARS-CoV-2 vaccine booster on vaccine response in immunosuppressed adults with inflammatory conditions: protocol for a multicentre randomised controlled trial and nested mechanistic substudy (Vaccine Response On/Off Methotrexate (VROOM) study). BMJ Open, 12 (5). e062599. ISSN 2044-6055

Reynolds, C.J., Jones, C., Blohmke, C.J. et al. (7 more authors) (2014) The serodominant secreted effector protein of Salmonella, SseB, is a strong CD4 antigen containing an immunodominant epitope presented by diverse HLA class II alleles. Immunology, 143 (3). 438 - 446.